| Year |
Citation |
Score |
| 2019 |
Chen C, Dienhart JA, Bolton EC. Correction: Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells. Plos One. 14: e0213800. PMID 30865707 DOI: 10.1371/Journal.Pone.0213800 |
0.355 |
|
| 2018 |
Copeland BT, Pal SK, Bolton EC, Jones JO. The androgen receptor malignancy shift in prostate cancer. The Prostate. PMID 29473182 DOI: 10.1002/Pros.23497 |
0.394 |
|
| 2017 |
Park HJ, Bolton EC. RET-mediated glial cell line derived neurotrophic factor signaling inhibits mouse prostate development. Development (Cambridge, England). PMID 28506996 DOI: 10.1242/Dev.145086 |
0.438 |
|
| 2016 |
Smith JW, Ford NA, Thomas-Ahner JM, Moran NE, Bolton EC, Wallig MA, Clinton SK, Erdman JW. Mice lacking β-carotene-15,15'-dioxygenase (BCO1) exhibit reduced serum testosterone, prostatic androgen receptor signaling, & prostatic cellular proliferation. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. ajpregu.00261.2016. PMID 27629887 DOI: 10.1152/Ajpregu.00261.2016 |
0.407 |
|
| 2016 |
Chen C, Dienhart JA, Bolton EC. Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells. Plos One. 11: e0156145. PMID 27203692 DOI: 10.1371/Journal.Pone.0156145 |
0.42 |
|
| 2015 |
Kim YC, Chen C, Bolton EC. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells. Plos One. 10: e0138286. PMID 26372468 DOI: 10.1371/Journal.Pone.0138286 |
0.43 |
|
| 2015 |
Park HJ, Bolton EC. Glial cell line-derived neurotrophic factor induces cell proliferation in the mouse urogenital sinus. Molecular Endocrinology (Baltimore, Md.). 29: 289-306. PMID 25549043 DOI: 10.1210/Me.2014-1312 |
0.368 |
|
| 2015 |
Zhou Y, Bolton EC, Jones JO. Androgens and androgen receptor signaling in prostate tumorigenesis. Journal of Molecular Endocrinology. 54: R15-29. PMID 25351819 DOI: 10.1530/Jme-14-0203 |
0.378 |
|
| 2012 |
Mukherjee S, Cruz-Rodríguez O, Bolton E, Iñiguez-Lluhí JA. The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs. The Journal of Biological Chemistry. 287: 31195-206. PMID 22829593 DOI: 10.1074/Jbc.M112.395210 |
0.447 |
|
| 2009 |
Jones JO, Bolton EC, Huang Y, Feau C, Guy RK, Yamamoto KR, Hann B, Diamond MI. Non-competitive androgen receptor inhibition in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 106: 7233-8. PMID 19363158 DOI: 10.1073/Pnas.0807282106 |
0.416 |
|
| 2007 |
Bolton EC, So AY, Chaivorapol C, Haqq CM, Li H, Yamamoto KR. Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes & Development. 21: 2005-17. PMID 17699749 DOI: 10.1101/Gad.1564207 |
0.477 |
|
| 2007 |
So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. Plos Genetics. 3: e94. PMID 17559307 DOI: 10.1371/Journal.Pgen.0030094 |
0.376 |
|
| 2007 |
Yarrington RM, Chen J, Bolton EC, Boeke JD. Mn2+ suppressor mutations and biochemical communication between Ty1 reverse transcriptase and RNase H domains. Journal of Virology. 81: 9004-12. PMID 17537863 DOI: 10.1128/Jvi.02502-06 |
0.486 |
|
| 2005 |
Bolton EC, Coombes C, Eby Y, Cardell M, Boeke JD. Identification and characterization of critical cis-acting sequences within the yeast Ty1 retrotransposon. Rna (New York, N.Y.). 11: 308-22. PMID 15661848 DOI: 10.1261/Rna.7860605 |
0.468 |
|
| 2003 |
Bolton EC, Boeke JD. Transcriptional interactions between yeast tRNA genes, flanking genes and Ty elements: a genomic point of view. Genome Research. 13: 254-63. PMID 12566403 DOI: 10.1101/Gr.612203 |
0.463 |
|
| 2002 |
Bolton EC, Mildvan AS, Boeke JD. Inhibition of reverse transcription in vivo by elevated manganese ion concentration. Molecular Cell. 9: 879-89. PMID 11983178 DOI: 10.1016/S1097-2765(02)00495-1 |
0.494 |
|
| Show low-probability matches. |